SHL Telemedicine Ltd - American Depositary Shares

SHL Telemedicine Ltd - American Depositary Shares Depository Receipt · US78423T2006 · SHLT (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of SHL Telemedicine Ltd - American Depositary Shares
No Price
Company Profile for SHL Telemedicine Ltd - American Depositary Shares Depository Receipt
SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. The company offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; Cardio'B, a portable device to transmit a 12-lead ECG; and Cardio Beeper 12/12, a hand-held ECG transmitter device for personal use that transmits a full ECG reading to the monitoring center. It also provides central communication module, a telecommunication device that transmits medical data to its telemedicine centers from various medical monitoring devices; TeleWeight, a trans-telephonic weight monitoring device for personal use; TelePress, a remote blood pressure monitoring device for personal use; TeleBreather, a remote electronic handheld device to test the working of lungs; and TelePulse Oximeter, an electronic handheld diagnostic device to measure the saturation level of oxygen in blood, as well as pulse rate. The company offers its telemedicine services and devices to subscribers using telephonic and internet communication technology. It serves patients, health insurance companies, hospitals, clinics, physicians, and other health care providers. The company has a collaboration agreement with Mayo Clinic to evaluate the incidence of emergency department visits, re-hospitalizations, and major adverse cardiovascular events over a period of 90 days after first hospitalization for a heart attack for patients using SmartHeart FDA approved 12 lead ECG; and collaboration agreement with the Hebrew University of Jerusalem and the Hadassah Medical Center to develop an artificial intelligence tool for predicting future life-threatening cardiac events based on 12 Lead ECG monitoring. SHL Telemedicine Ltd. was founded in 1987 and is headquartered in Tel Aviv, Israel.

Company Data

Name SHL Telemedicine Ltd - American Depositary Shares
Company SHL Telemedicine Ltd.
Symbol SHLT
Website https://www.shl-telemedicine.com
Primary Exchange XNAS NASDAQ
ISIN US78423T2006
Asset Class Depository Receipt
Sector Healthcare
Industry Medical - Healthcare Information Services
CEO David Arnon
Market Capitalization 34 Mio
Country Israel
Currency USD
Employees 0,6 T
Address Ashdar Building, 67891 Tel Aviv
IPO Date 2023-04-03

Ticker Symbols

Name Symbol
NASDAQ SHLT
More Shares
Investors who hold SHL Telemedicine Ltd - American Depositary Shares also have the following shares in their portfolio:
BNY MELLON INTERNATIONAL EQUITY ETF
BNY MELLON INTERNATIONAL EQUITY ETF ETF
GraniteShares 3x Short Amazon Daily ETP
GraniteShares 3x Short Amazon Daily ETP ETF